News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Wins EU Backing for First Meningitis B Vaccine


1/22/2013 8:15:28 AM

Novartis clinched European approval for the first vaccine against meningitis B, and will seek to sell the drug as soon as possible. "Novartis is working with health authorities to provide access to Bexsero as soon as possible," the Swiss drugmaker said in a statement on Tuesday. There is currently no approved vaccine offering broad protection against "MenB," this particular type of meningitis. Novartis won a European panel backing for Bexsero in November. Bexsero's commercial success still depends on whether individual governments decide to add it to routine vaccination programs.

Read at Reuters
Read at BusinessWeek
Read at RTT News
Read at BBC News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES